The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse

Phosphorodiamidate morpholino oligonucleotides (PMO) are used as a promising exon-skipping gene therapy for Duchenne muscular dystrophy (DMD). One potential complication of high dose PMO therapy is its transient accumulation in the kidneys. Therefore new urinary biomarkers are needed to monitor this...

詳細記述

保存先:
書誌詳細
出版年:Toxicol Rep
主要な著者: Zhang, Aiping, Uaesoontrachoon, Kitipong, Shaughnessy, Conner, Das, Jharna R., Rayavarapu, Sree, Brown, Kristy J., Ray, Patricio E., Nagaraju, Kanneboyina, van den Anker, John N., Hoffman, Eric P., Hathout, Yetrib
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2015
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4512206/
https://ncbi.nlm.nih.gov/pubmed/26213685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.toxrep.2015.05.008
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料